4//SEC Filing
Geffner Michael 4
Accession 0001764013-25-000109
CIK 0001764013other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 4:15 PM ET
Size
5.9 KB
Accession
0001764013-25-000109
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Geffner Michael
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-07-09$17.24/sh−1,160$19,998→ 224,210 total
Footnotes (2)
- [F1]On April 2, 2024, the holder was granted 54,978 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 4, 2024, of which 3,436 of these RSUs vested on July 2, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 - $17.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0002007249
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 4:15 PM ET
- Size
- 5.9 KB